Upgrade to SI Premium - Free Trial

CG Oncology (CGON) PT Raised to $82 at Truist Securities

May 14, 2026 6:08 AM
Truist Securities analyst Greg Renza raised the price target on CG Oncology (NASDAQ: CGON) to $82.00 (from $77.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change